Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1984 Sep 1;131(5):443–447.

Is cimetidine being prescribed indiscriminately? An analytic survey of patients who present with symptoms of peptic ulcer disease.

T J Elmslie, W W Rosser, S J Sollars, M C Champion, R S Roberts
PMCID: PMC1483477  PMID: 6467116

Abstract

An analytic survey was done to determine the influence of previously documented peptic ulcer disease (PUD) on the frequency of prescribing cimetidine to patients who present at a family medicine centre with symptoms of PUD. It was found that of 293 patients who presented with such symptoms over 1 year cimetidine was prescribed to 57 (19%). From the 236 patients who did not receive cimetidine 57 patients were selected at random for comparison. Information on these two groups of patients was obtained by chart review. The patients who received cimetidine were found to be significantly more likely (p less than 0.001) to have previously documented PUD than those who did not receive cimetidine. In patients in whom subsequent confirmation of PUD was not obtained, either because the results of investigations were negative or because the investigations were not ordered, cimetidine was prescribed to 63% of those who had previously documented PUD, compared with only 6% of those who did not. Of the patients who were investigated 73% of those with previously documented PUD had positive results, compared with 8% of those without previously documented PUD. The positive results were obtained by endoscopic examination in 88% of the patients with previously documented PUD, whereas upper gastrointestinal tract roentgenography was the definitive test in 73% of the patients without previously documented PUD. These findings suggest that previously documented PUD influences both the frequency of prescribing cimetidine and the investigations that are carried out.

Full text

PDF
444

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cocco A. E., Cocco D. V. A survey of cimetidine prescribing. N Engl J Med. 1981 May 21;304(21):1281–1281. doi: 10.1056/NEJM198105213042108. [DOI] [PubMed] [Google Scholar]
  2. Gifford L. M., Aeugle M. E., Myerson R. M., Tannenbaum P. J. Cimetidine postmarket outpatient surveillance program. Interim report on phase I. JAMA. 1980 Apr 18;243(15):1532–1535. [PubMed] [Google Scholar]
  3. Hall K. W., Behun M., Irvine-Meek J., Otten N. Use of cimetidine in hospital patients. Can Med Assoc J. 1981 Jun 15;124(12):1579–1585. [PMC free article] [PubMed] [Google Scholar]
  4. Lafrate R. P., Russel W. L. Nonindicated use of cimetidine. Am J Hosp Pharm. 1980 Nov;37(11):1462–1465. [PubMed] [Google Scholar]
  5. Marks I. N. Current therapy in peptic ulcer. Drugs. 1980 Oct;20(4):283–299. doi: 10.2165/00003495-198020040-00003. [DOI] [PubMed] [Google Scholar]
  6. Sackett D. L. Bias in analytic research. J Chronic Dis. 1979;32(1-2):51–63. doi: 10.1016/0021-9681(79)90012-2. [DOI] [PubMed] [Google Scholar]
  7. Schade R. R., Donaldson R. M., Jr How physicians use cimetidine: a survey of hospitalized patients and published cases. N Engl J Med. 1981 May 21;304(21):1281–1284. doi: 10.1056/NEJM198105213042109. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES